From 2c42eb6e11fb9bb5ab64ee62f1dc1f46d5c23cfd Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:29:58 +0100 Subject: [PATCH] [logseq-plugin-git:commit] 2024-03-11T09:29:56.682Z --- pages/STOP2030___Web___Posts.md | 2 ++ 1 file changed, 2 insertions(+) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index 4f065abb..bb0e98cc 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -7,4 +7,6 @@ This clinical trial is a Cohort Event Study aimed at evaluating the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within large populations, matched against the standard dose albendazole currently in use against STH. We expect to recruit around 20 thousand school-aged children between 5 and 14 years old in Kenya and Ghana. + + #+END_VERSE \ No newline at end of file